ARTICLE | Company News
Almac, Genentech enter cancer collaboration
June 16, 2015 2:10 AM UTC
The Almac Discovery oncology subsidiary of Almac Group Ltd. (Craigavon, U.K.) granted the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY) development and commercialization rights to its preclinical ubiquitin-specific protease inhibitors. ...